Literature DB >> 21828732

Size-controlled synthesis of monodispersed gold nanoparticles stabilized by polyelectrolyte-functionalized ionic liquid.

Changsheng Shan1, Fenghua Li, Fuyu Yuan, Guifu Yang, Li Niu, Qiang Zhang.   

Abstract

The size-controlled synthesis of monodispersed gold nanoparticles (AuNPs) stabilized by polyelectrolyte-functionalized ionic liquid (PFIL) is described. The resulting AuNPs' size, with a narrow distribution, can be tuned by the concentration of HAuCl(4). Such PFIL-stabilized AuNPs (PFIL-AuNPs) showed a high stability in water at room temperature for at least one month; they were also quite stable in solutions of pH 7-13 and high concentration of NaCl. In addition, the PFIL-AuNPs exhibited obvious electrocatalytical activity toward β-nicotinamide adenine dinucleotide (NADH for short, a cofactor in enzymatic reactions of NAD(+)/NADH(-)-dependent dehydrogenases) oxidation, suggesting a potential application for bioelectroanalysis.

Entities:  

Year:  2008        PMID: 21828732     DOI: 10.1088/0957-4484/19/28/285601

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  3 in total

1.  Size-controlled synthesis of monodispersed gold nanoparticles via carbon monoxide gas reduction.

Authors:  Joseph K Young; Nastassja A Lewinski; Robert J Langsner; Laura C Kennedy; Arthi Satyanarayan; Vengadesan Nammalvar; Adam Y Lin; Rebekah A Drezek
Journal:  Nanoscale Res Lett       Date:  2011-06-16       Impact factor: 4.703

2.  Near-Infrared Plasmonic Assemblies of Gold Nanoparticles with Multimodal Function for Targeted Cancer Theragnosis.

Authors:  Seong-Eun Kim; Bo-Ram Lee; Hohyeon Lee; Sung Duk Jo; Hyuncheol Kim; You-Yeon Won; Jeewon Lee
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

3.  Gold Nanoparticles: An Efficient Antimicrobial Agent against Enteric Bacterial Human Pathogen.

Authors:  Shahzadi Shamaila; Noshin Zafar; Saira Riaz; Rehana Sharif; Jawad Nazir; Shahzad Naseem
Journal:  Nanomaterials (Basel)       Date:  2016-04-14       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.